Anastrozole is an aromatase inhibitor indicated for: • Adjuvant treatment of postmenopausal women with hormone receptorpositive early breast cancer
(1.1) • First-line treatment of postmenopausal women with hormone receptorpositive or hormone receptor unknown locally advanced or metastatic breast cancer
(1.2) • Treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. Patients with ERnegative disease and patients who did not respond to previous tamoxifen therapy rarely responded to anastrozole
Sincerely Pharmaceutical Tech
Regards,
Client Success Team (CRM),
Please fill the all required fields....!!
Sincerely Packaging Labelling